Trials / Completed
CompletedNCT04778436
Macula Evolution in Patients With AMD Taking Oral Food Supplementation
Macular Drusen Evolution in Patients With Intermediate Age-related Macular Degeneration (AMD) Taking Oral Food Supplementation: an Open-label,Single-arm Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Laboratoires Thea · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
LT7082-001 is an open-label, single-arm pilot study. Patients with intermediate age-related macular degeneration (AMD) wil take T7082 during 12 months , an association of 4 food supplementations . The study objectives are to describe morphological changes and evolution of drusen in macula after a 12-month of food supplementation and to assess the safety of T7082
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | T7082 | Patients will take food supplementation for 12 months. For each patient : 5 visits with ophthalmogist and 6 phone call |
Timeline
- Start date
- 2021-01-13
- Primary completion
- 2022-01-24
- Completion
- 2022-01-24
- First posted
- 2021-03-03
- Last updated
- 2022-02-15
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04778436. Inclusion in this directory is not an endorsement.